CTLA-4 Gene Polymorphisms in Tunisian Patients with Graves' Disease
- 31 December 2001
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 101 (3) , 361-365
- https://doi.org/10.1006/clim.2001.5121
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A full genome screening in a large Tunisian family affected with thyroid autoimmune disordersGenes & Immunity, 2001
- Evidence for a New Graves Disease Susceptibility Locus at Chromosome 18q21American Journal of Human Genetics, 2000
- Further Evidence for a Susceptibility Locus on Chromosome 20q13.11 in Families with Dominant Transmission of Graves DiseaseAmerican Journal of Human Genetics, 1999
- A New Graves Disease–Susceptibility Locus Maps To Chromosome 20q11.2American Journal of Human Genetics, 1998
- CTLA4 Gene Polymorphism Confers Susceptibility to Graves' Disease in JapaneseThyroid®, 1997
- A CTLA‐4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidismClinical Endocrinology, 1997
- An Mse I RFLP in the Human CTLA4 PromotorBiochemical and Biophysical Research Communications, 1996
- The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes RegistryHuman Molecular Genetics, 1996
- A thyroid hormone receptor β gene polymorphism associated with Graves’ diseaseJournal of Molecular Endocrinology, 1995
- ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASEAnnals of Human Genetics, 1955